This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://localhost/temp/predkladatel/
n9http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11110%2F10%3A7266%21RIV11-MSM-11110___/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11110%2F10%3A7266%21RIV11-MSM-11110___
rdf:type
n9:Vysledek skos:Concept
dcterms:description
Two common chemotherapeutic agents, Ifosfamide and cyclophosphamide, are isomers, bu only ifosfamide is known to cause nephrotoxicity and neurotoxicity. UPLC-ESI-QT0FMS-based metabolomics revealed five novel metabolites. The results suggest that precursors of thiodiglycolic acid, may be responsible for Ifosfamide encephalopathy and nephropathy. Two common chemotherapeutic agents, Ifosfamide and cyclophosphamide, are isomers, bu only ifosfamide is known to cause nephrotoxicity and neurotoxicity. UPLC-ESI-QT0FMS-based metabolomics revealed five novel metabolites. The results suggest that precursors of thiodiglycolic acid, may be responsible for Ifosfamide encephalopathy and nephropathy.
dcterms:title
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QT0FMS-based metabolomics Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QT0FMS-based metabolomics
skos:prefLabel
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QT0FMS-based metabolomics Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QT0FMS-based metabolomics
skos:notation
RIV/00216208:11110/10:7266!RIV11-MSM-11110___
n3:aktivita
n15:V
n3:aktivity
V
n3:cisloPeriodika
7
n3:dodaniDat
n10:2011
n3:domaciTvurceVysledku
Idle, Jeffrey R.
n3:druhVysledku
n12:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n6:predkladatel
n3:idSjednocenehoVysledku
251327
n3:idVysledku
RIV/00216208:11110/10:7266
n3:jazykVysledku
n8:eng
n3:klicovaSlova
Ifosfamide; Cyclophosphamide; Metabolomics; Ultra-performance liquid chromatography; Time-of-flight mass spectrometry; Tandem mass spectrometry CHROMATOGRAPHY-PHOTOGRAPHY-DENSITOMETRY; BIOLOGICALLY-ACTIVE METABOLITE; CONTINUOUS-INFUSION; MASS-SPECTROMETRY; METHYLENE-BLUE; PHOSPHORAMIDE MUSTARD; URINARY METABOLITES; MAGNETIC-RESONANCE; CANCER-PATIENTS; IDENTIFICATION
n3:klicoveSlovo
n4:CANCER-PATIENTS n4:Time-of-flight%20mass%20spectrometry n4:BIOLOGICALLY-ACTIVE%20METABOLITE n4:Metabolomics n4:Cyclophosphamide n4:PHOSPHORAMIDE%20MUSTARD n4:Ifosfamide n4:MASS-SPECTROMETRY n4:CONTINUOUS-INFUSION n4:URINARY%20METABOLITES n4:IDENTIFICATION n4:Tandem%20mass%20spectrometry%20CHROMATOGRAPHY-PHOTOGRAPHY-DENSITOMETRY n4:Ultra-performance%20liquid%20chromatography n4:METHYLENE-BLUE n4:MAGNETIC-RESONANCE
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[E38BDE661F47]
n3:nazevZdroje
BIOCHEMICAL PHARMACOLOGY
n3:obor
n16:FR
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
6
n3:rokUplatneniVysledku
n10:2010
n3:svazekPeriodika
80
n3:tvurceVysledku
Krausz, Kristopher W Idle, Jeffrey R. Patterson, Andrew D Li, Fei Hoefer, Constance C Gonzalez, Frank J
n3:wos
000281428800014
s:issn
0006-2952
s:numberOfPages
12
n14:organizacniJednotka
11110